Welcome to RAPBlog

For commercial products that are borderline medical devices, it would be easy to argue that qualifying as a medical device is something to be avoided.

It’s about time that we started to look seriously at standardising some aspects of desktop digital reader technology.

Whatever your opinion about replacing people with machines, no one will suffer a serious injury for an incorrect line-call decision. This was proved at Wimbledon when someone accidentally turned Hawk-Eye off mid-game – a player got a bit annoyed, a commentator was confused, no one died. AI in medical devices is a different ball game.

Our projects are well planned, often in phases with their own mini-objectives and they build towards a defined goal. We factor-in some deviation because research is unpredictable. Our version of project drift is a gradual and often imperceptible process – an accumulation of small, unplanned activities that slowly nudge a project off-track – and often takes much longer than expected to get back on-track.

We deliver focused services for various reasons. Generalists can face pressures that are neither science nor customer related.

When regulations prevent solutions that improve and save lives, it’s time to act and put it right.

I knew that getting products on the market wasn’t easy, but goodness, it sounds really, really hard.

Are we missing growth potential if healthcare diagnostics remains our focus at the expense of creating tools for other sectors?

I haven’t heard of anyone who doubts the staggering potential of the point-of-care diagnostics industry and the positive impact that it could provide to many areas of life. The benefits for healthcare alone should attract the immediate attention of anyone taking a strategic view of developing the IVD sector for a better future. I’m not demanding eye-watering levels of financial investment (although… you know). I’m just proposing that we would benefit from a sense of directi

The success of lateral flow technology in diagnosing covid and detecting pregnancy has provided the foundations for a huge proliferation of lateral flow products. The technology continues to improve and expand into new areas, but I still think that medical diagnostics are massively under-valued, under-used and under-funded. I know that the rapid in vitro diagnostics industry operates in a complex landscape. Healthcare is a tangled web at the best of times, with sensitive fina

I started working the in vitro diagnostics industry in 2022 and in a relatively short time, became acquainted with its jargon. It’s something I’d done many times before, having spent more than 20 years marketing for business publishers and trade event organisers. I had to immerse myself (albeit briefly) in the language of multiple industries, big sectors such as building, travel, oil & gas, agriculture and food, as well as more specialist areas such as dredging & port constru